Outcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)
Year: 2019
Type: article
Study design: Observational Study
Source: Annals of Oncology
Institutions: Essen University Hospital, Universitätsklinikum Tübingen, The University of Sydney, Melanoma Institute Australia, University Medical Center of the Johannes Gutenberg University Mainz, Vanderbilt University Medical Center, University Hospital Cologne, Medizinische Hochschule Hannover, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, University Hospital Münster, Universitätsklinikum Würzburg, Charité – Universitätsmedizin Berlin, University Hospital Schleswig-Holstein, University Hospital Bonn, Elbe Kliniken Stade-Buxtehude
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2978190594